1. Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma
   Jose J.G. Marin et al, 2020, Cells CrossRef
2. Identifying Critical States of Complex Diseases by Single-Sample Jensen-Shannon Divergence
   Jinling Yan et al, 2021, Frontiers in Oncology CrossRef
3. FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
   Xiongfei Chen et al, 2020, Open Life Sciences CrossRef
4. FXYD proteins and sodium pump regulatory mechanisms
   John Q. Yap et al, 2021, Journal of General Physiology CrossRef
5. FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase α1 and Affecting Cell Autophagy and Apoptosis in Colorectal Cancer
   Wen Luo et al, 2021, BioMed Research International CrossRef
6. MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6
   Zheng-Min Li et al, 2016, Journal of Drug Targeting CrossRef
7. Clinical significance of P‑class pumps in cancer (Review)
   Sophia Themistocleous et al, 2021, Oncology Letters CrossRef
8. Potential Biomarkers of miR-371–373 Gene Cluster in Tumorigenesis
   Junaid Ali Shah et al, 2021, Life CrossRef
9. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma
   Mengwei Wu et al, 2019, Frontiers in Endocrinology CrossRef
10. FXYD6 promotes thermal nociception by regulating TRPV1
    Hao Luo et al, 2021, Molecular Pain CrossRef
11. Identification of FXYD6 as the novel biomarker for glioma based on differential expression and DNA methylation
    Weiliang Hou et al, 2023, Cancer Medicine CrossRef
12. Ion channels expression and function are strongly modified in solid tumors and vascular malformations
    Antonella Biasiotta et al, 2016, Journal of Translational Medicine CrossRef